POSTERS

• P20-01 • THERAPEUTIC HPV16/18 ADENOVIRUS-VECTOR-BASED VACCINE PROOF OF CONCEPT IN MICE AND NON HUMAN PRIMATES See abstract > S. Selina Khan • P12-22 • NON-INVASIVE FIRST-VOID URINE SAMPLING AND ACCEPTABILITY TO MONITOR THE IMPACT OF VACCINATION AGAINST HPV See abstract > S. Severien Van Keer • P12-21 • COMPATIBILITY OF GENEFIRST PAPILLOPLEX™ HR-HPV GENOTYPING ASSAY FOR TESTING FIRST VOID URINE SPECIMENS See abstract > D. Devarshi Kapadia • P08-03 • MicroRNA-106b promotes cell migration by targeting DAB2 in cervical carcinoma See abstract > L. Li Geng • P07-10 • HPV PREVALENCE AND TYPE-DISTRIBUTION IN CORRELATION WITH AGE AND CERVICAL CYTOLOGIC ABNORMALITIES IN CROATIAN FEMALE POPULATION See abstract > T. Tatjana Marijan • P11-08 • EARLY RESULTS OF HPV-VACCINATION PROGRAM WITH QUADRIVALENT HPV VACCINE DEPENDING ON VACCINE COVERAGE IN 3 DISTRICTS OF MOSCOW REGION, RUSSIA See abstract > N. Nina Zarochentseva • P07-01 • PROLONGED ORAL CONTRACEPTIVES USE AND THE RISK OF ACQUISITION OF HUMAN PAPILLOMAVIRUS TYPE 16/18 INFECTIONS See abstract > I. Indira Adhikari • P12-09 • PERFORMANCE OF COBAS 4800 TEST TO DETECT HRHPV IN HSIL+ LESIONS See abstract > M. Maria luisa Mateos • P12-12 • EVALUATION OF ONCOGENIC HUMAN PAPILLOMAVIRUS RNA AND DNA TEST WITH LIQUID-BASED CYTOLOGY IN PRIMARY CERVICAL CANCER SCREENING POPULATION. See abstract > A. Alicia Sáez • P12-18 • HPV-RELATED LESIONS IN ANAL AND CERVIX PAP-SMEARS IN HIV+-PATIENTS UNDER ANTI-RETROVIRAL TREATMENT. INTEREST OF CYTOLOGY COUPLED TO RAPID HPV PCR. See abstract > F. Francine Walker • P03-02 • OBSTETRIC OUTCOME AFTER CERVICAL CONIZATION OR LLETZ: A RETROSPECTIVE STUDY IN THE UNIVERSITY HOSPITAL OF LEUVEN See abstract > H. Hannah Verschuere • P01-09 • EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR - C AND PODOPLANIN IN SQUAMOUS INTRAEPITHELIAL LESION See abstract > N. Neila Gois Speck • P07-08 • Cervical screening history and rare histological types of invasive cervical cancer: a population-based nested case-control study in Sweden See abstract > J. Jiayao Lei • P04-01 • CANCER SCREENING OF CERVICAL PREGNANCY IN MATERNITY CENTER HEALTH NABIL CHOUCAIR AND HOSPITAL INSTITUTE SOCIAL IN DAKAR ( SENEGAL) : ABOUT 67 CASES See abstract > O. Omar Gassama • P12-19 • DETECTION OF HIGH-RISK HPV GENOTYPES AMONG THE ECUADORIAN FEMALE POPULATION: STUDY OF 1643 CASES WITH ROCHE COBAS 4800 HPV See abstract > H. Hector Zambrano • P12-07 • Population-based HPV Testing Performance: Potential False-negative HPV Results in a Cervical Cancer Surveillance Population See abstract > M. Ming Guo • P07-03 • PREVALENCE OF HPV INFECTION AMONG ADOLESCENT GIRLS IN MOSCOW REGION, RUSSIAN FEDERATION See abstract > J. Julia Belaya • P01-05 • Thin HSIL of the Cervix: Detecting a Variant of High-Grade Squamous Intraepithelial Lesions with a p16INK4a - Antibody See abstract > O. Olaf REICH • P01-07 • ESTIMATING THE MANAGEMENT COST OF CERVICAL INTRAEPITHELIAL NEOPLASIA IN THE UK See abstract > M. Mathieu Uhart • P17-11 • THE EFFECT OF ANAL CANCER AWARENESS AND ANXIETY ON SCREENING IN MEN WHO HAVE SEX WITH MEN See abstract > A. Alan Nyitray • P10-02 • Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp See abstract > K. Kazufumi Nakashima • P12-03 • XPERT® HPV ASSAY EVALUATION FOR HPV TESTING ON FORMALIN FIXED PARAFFIN EMBEDDED OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS See abstract > M. Maria Benevolo • P07-14 • EXAMINING LUNG CANCER TISSUE FOR HUMAN PAPILLOMAVIRUS See abstract > E. Efstathia Panotopoulou • P09-01 • History and future of HPV College See abstract > T. Tomas Fait • P12-11 • Comparison of the HPV DNA chip test, the real time PCR HPV test and the Hybrid capture II test in Atypical Squamous Cells of Undetermined Significance population See abstract > J. Jong Sup Park • P12-05 • EVALUATION OF THE MANAGEMENT OF HR-HPV+/PAPTEST-WOMEN: RESULTS AT 1-YEAR RECALL. See abstract > C. Claudio Di Cristofano • P01-06 • CERVICAL CANCER SURVIVORS AND HEALTH CARE USE: A POPULATION-BASED REGISTER STUDY See abstract > M. Malene Skorstengaard • P17-08 • IS THERE EVIDENCE FOR CERVICAL CANCER SCREENING IN ELDERLY WOMEN? See abstract > L. Lise holst Thamsborg • P18-02 • The prevalence of human papillomavirus infection and other sexually transmitted infections in the anus of Japanese men who have sex with men: A molecular and cytological analysis See abstract > H. Hiroaki Iwamoto • P01-08 • Dynamin 2 inhibitors as novel therapeutic agents in cervical cancer cells See abstract > L. Lee Jeong-Won • P04-04 • HUMAN PAPILLOMAVIRUS (HPV) PREVALENCE AND CORRELATION WITH ABNORMAL CERVICAL CYTOLOGY FINDINGS IN WOMEN FROM CROATIA: A COMPOUNDING EFFECT OF LOW-RISK/HIGH-RISK HPV CO-INFECTION See abstract > Z. Zora Profozic • P04-05 • Cytological evaluation in penile samples with human papillomavirus See abstract > K. Kazuyoshi Shigehara • P14-01 • PRECANCEROUS AND CANCEROUS LESIONS OF THE UTERINE CERVIX IN KINSHASA: ASSOCIATION WITH HIV INFECTION See abstract > C. Catherine Ali-Risasi • P11-02 • THE POTENTIAL IMPACT OF PAPILLOMAVIRUS VACCINES IN OPERABLE CERVICAL TUMOURS See abstract > M. Mario Cunha • P01-02 • The expression of S100A14 into cytosol is associated with cervical cancer growth. See abstract > J-H. Jae-hoon Kim • P17-04 • HPV-positivity rate in randomised HPV self-sampling study among Slovenian non-responders: comparison of the results between three self-sampling devices See abstract > N. Nataša Nolde • P15-03 • PERFORMANCE OF THE ONCOE6 TEST FOR HIGH-GRADE CERVICAL DISEASE AND CANCER DETECTION AMONG HONDURAN WOMEN See abstract > A. Annabelle Ferrera • P04-06 • RESULTS OF CONVENTIONAL CYTOLOGY PAP SMEAR VERSUS LIQUID-BASED CYTOLOGY ASSOCIATED WITH HPV DNA TESTING IN WOMEN WITH UTERINE CERVICAL ECTOPY. See abstract > N. Neila Speck • P01-01 • Prognostic factors affecting survival in cervical cancer patients with recurrent parenchymal lung lesions without other organ involvement See abstract > B. Bae Duk-Soo • P07-13 • German population-based analysis of risk factors for prevalent high risk HPV infections See abstract > L. Lisa Wang • P07-09 • SEROPREVALENCE OF 19 HUMAN PAPILLOMAVIRUS (HPV) TYPES IN A NATIONWIDE REPRESENTATIVE CROSS-SECTIONAL SURVEY IN GERMANY IN THE PRE-VACCINE ERA See abstract > A. Anna Loenenbach • P01-04 • Application of Topical Imiquimod for Treatment Cervical Intraepithelial Neoplasia in Young Women: A preliminary result of a pilot study See abstract > J-H. Joo-hyun Nam • P17-07 • PRELIMINARY EVALUATION OF CERVICAL CANCER SCREENING BY CYTOLOGY AND HPV TESTING IN NORTH-WESTERN REGION OF ROMANIA See abstract > O. Ofelia Suteu • P16-02 • VALIDATION OF A NEW METHOD FOR HIGH RISK HPV DETECTION WITH THE XPERT® HPV ASSAY IN PAP-SPIN™ MEDIUM See abstract > C. Claude Cuvelier • P12-10 • BARRIERS TO AND FACILIATORS OF HPV SELF-TESTING AMONG WOMEN POST TREATMENT OF HIGH GRADE CIN See abstract > M. Miriam Minst • P07-15 • GENITAL WARTS IN SCANDINAVIAN WOMEN BEFORE AND AFTER IMPLEMENTATION OF HPV VACCINATION See abstract > C. Christian Munk • P07-11 • HR HPV VIRUS PRESENCE IN WOMEN - COVERED BY NATIONAL SCREENING PROGRAM FOR CERVICAL CARCINOMA IN POLAND See abstract > W. Wlodzimierz Olszewski • P03-01 • FISHER CONE BIOPSY IN THE MANAGEMENT OF CERVICAL CANCER PRECURSORS See abstract > A. Alfred Dörr • P16-03A • Application of Robotic Single-Site Surgery for benign ovarian tumor See abstract > S-H. Sang-hoon Kwon • P16-03B • Robotic Single-Site Surgery in Carcinoma In Situ of Cervix: A pilot study See abstract > S-H. Sang-hoon Kwon • P15-02 • NEW SCREENING PROTOCOL WITH DUAL-STAINED CYTOLOGY TRIAGE See abstract > M. Maria dolores Comes • P17-12 • FOCALPOINT COMPUTER-ASSISTED PAP TEST SCREENING: VALIDATION TECHNOLOGY STUDY FOR IMPLEMENTATION IN A PUBLIC HEALTH SERVICE See abstract > T. Toni ricardo Martins • P10-01 • COMPARATIVE EVALUATION OF THREE HPV GENOTYPING ASSAYS ON FFPE SAMPLES OF HEAD AND NECK CANCER See abstract > J. Joël Mossong • P12-25 • XPERT HPV ASSAY AS A PROMISING TEST IN CLINICAL SETTING: ANALYTIC AND DIAGNOSTIC PERFORMANCES. See abstract > S. Sandra Rosini • P07-07 • CERVIСAL CANCER INCIDENCE AND MORTALITY IN THE RUSSIAN FEDERATION See abstract > S. Susanna Kharit • P06-01 • HEALTH OUTCOME AND BUDGET IMPACT ANALYSIS OF A COMBINED CERVICAL SCREENING STRATEGY BASED ON PRIMARY HPV SCREENING AND TRIAGE WITH DUAL STAIN CYTOLOGY IN BELGIUM See abstract > K. Katleen Vandeweyer • P04-02 • Clinical Significance of Atypical Glandular Cells on Cytology See abstract > H. Hyeong ju Kim • P16-01 • DETECTION AND QUANTIFICATION OF HPV-mRNA IN SENTINEL LYMPH NODES OF CERVICAL CANCER PATIENTS BY DIGITAL PCR AND REAL-TIME PCR – A COMPARISON OF METHODS See abstract > K. Katrin Carow • P15-05 • EXPRESSION OF p16/Ki67 DUAL-STAINING DEPENDING ON MOST COMMON HPV GENOTYPES IN CERVICAL LESIONS See abstract > I. Ines Krivak Bolanca • P07-05 • EPIDEMIOLOGY OF HOSPITALIZATIONS RELATED TO CERVICAL CANCER IN SPAIN (2009-2013). See abstract > R. Ruth Gil-Prieto • P17-01 • STUDY PROCOTOL OF THE CHOiCE TRIAL: A THREE-ARMED, RANDOMIZED, CONTROLLED TRIAL OF HOME-BASED HPV SELF-SAMPLING FOR NON-PARTICIPANTS IN AN ORGANIZED CERVICAL CANCER SCREENING PROGRAM See abstract > B. Berit Andersen • P12-13 • THE IEO LAB TRANSITION FROM HC2 TO COBAS IN HPV DETECTION: SENSITIVITY AND SPECIFITY FOR CIN2+ IN 10213 CONSECUTIVE SAMPLES. See abstract > M. Maria teresa Sandri • P17-06 • SELF-SAMPLING IN CIN2+ DETECTION: SENSITIVITY AND SPECIFICITY OF DIFFERENT RLU CUT-OFF IN SPECIMENS FROM 786 WOMEN See abstract > M. Maria teresa Sandri • P11-01 • Effectiveness of HPV vaccine for the prevention of cervical abnormalities in Saitama City, Japan in 2015 See abstract > D. Daisuke Hotta • P11-04 • 9-VALENT HPV VACCINE DEVELOPMENT: INNOVATIVE REGULATORY APPROACH USING A PHASE IIB/III DESIGN AND AN IMMUNOLOGICAL BRIDGING TO ESTABLISH EFFICACY See abstract > A. Allison Fisher • P17-09 • CURRENT STANDARDS AND OPTIONS FOR NATIONAL CERVICAL CANCER SCREENING PROGRAMME IN CROATIA See abstract > J. Josko Zekan • P11-03 • HPV Vaccine Uptake Rate in 9-21 Year Old Adolescents during Well-Child Visits from 2007 to 2013 in the U.S. See abstract > B. Brianna Lindsay • P11-05 • NO INCREASE IN GUILLAIN-BARRE SYNDROME HOSPITALISATIONS AFTER HPV VACCINE PROGRAM IMPLEMENTATION: AN ADMINISTRATIVE DATABASE ANALYSIS IN QUÉBEC, CANADA See abstract > C. Chantal Sauvageau • P05-02 • EVALUATION OF SEEGENE ANYPLEX II HPV GENOTYPING ASSAYS USING CERVICAL SAMPLES See abstract > S. Sepehr Tabrizi • P19-02 • ADVANCED VULVAR CANCER. TWO DIFFERENT CASES OF THE SAME DISEASE See abstract > A. Ana maria Serrano • P07-12 • Anal High Risk HVP: Gender Comparison For Detection In Puerto Rican Population See abstract > A. Alexandra Rosado • P12-17 • EVALUATION OF THE ROCHE COBAS®HPV ASSAY WITH COLLI-PEETM COLLECTED, UCM PRESERVED URINE. See abstract > A. Alex Vorsters • P12-16 • PILOT FEASIBILITY STUDY ON USE OF THE XPERT HPV ASSAY WITH COLLI-PEE COLLECTED, UCM PRESERVED URINE. See abstract > V. Vanessa Vankerckhoven • P11-07 • The impact of the vaccination with bivalent HPV vaccine after electrosurgical conization in preventing of HPV infection in patients with high grade cervical intraepithelial neoplasia. See abstract > N. Natalya Volodko • P09-02 • POPULATION-BASED STUDY ABOUT THE KNOWLEDGE OF WOMEN ON SECONDARY PREVENTION OF CERVICAL CANCER. See abstract > M. Mónica Hernández Aragón • P12-02 • Improving strategies and test algorithms for HPV diagnostics See abstract > F. Francisco Aliaga-Lozano • P09-03 • STUDY ABOUT THE ANXIETY GENERATED BY THE RESULT OF SCREENING TECHNIQUES OF CERVICAL CANCER See abstract > L. Leyre Ruiz Campo • P11-06 • STUDY OF HPV VACCINATION IN GREECE DURING THE LAST FOUR YEARS See abstract > A. Anastasia Vatopoulou • P05-01 • COMPARISON OF ANYPLEX II HPV HR AND HC2 TESTING IN A SCREENING POPULATION See abstract > A. Alexander Luyten • P19-03 • IMMUNE ACTIVATION ENHANCES EPITHELIAL NERVE GROWTH IN LOCALIZED PROVOKED VULVODYNIA See abstract > P. Päivi Tommola • P12-01 • HPV infection among HIV-positive men: A three year revised experience of an diagnosis Laboratory. See abstract > A. Am Albuquerque • P12-04 • Audit of HPV subtypes in Northern Irish (NI) and Other Nationality (ON) patients with CIN111 biopsy See abstract > R. Rosemary Clarke • P07-04 • HPV AND BREAST CANCER...IS THERE A RELATIONSHIP? See abstract > S. Silvia Delgado García • P12-06 • IMPACT OF THE NEW MOLECULAR XPERT HPV ASSAY (CEPHEID) ON LABORATORY ORGANIZATION AND HPV MANAGEMENT See abstract > I. Isabelle Thibaut • P02-02 • SENSITIVITY AND SPECIFICITY OF CYTOLOGY AND COLPOSCOPY COMPARED TO FINAL HISTOLOGY AFTER LLETZ See abstract > A. Alexios Papanikolaou • P07-06 • HPV-RELATED CANCER IN NORWAY: SECULAR INCIDENCE TRENDS AND PREVENTIVE POTENTIAL OF HPV VACCINATION See abstract > B. Bo terning Hansen • P19-01 • Giant condyloma accuminatum mimicking vulvar verrucous carcinoma See abstract > F. Fatemeh Ghaemmaghaminori • P04-03 • Managment of abnormal pap smear during pregnancy See abstract > A. Anne christine Porn • P17-02 • CONCORDANCE BETWEEN SELF SAMPLING AND PROFESSIONALLY TAKEN CERVICAL HPV TEST- RESULT FROM A POPULATION BASED COHORT STUDY See abstract > L. Lovisa Bergengren • P01-03 • PROGNOSTIC RELEVANCE OF MULTIPLE HPV GENOTYPES IN CERVICAL CARCINOMA See abstract > G. Gabriella Lillsunde Larsson • P15-04 • SYSTEMS BIOLOGY STUDY FOCUSING ON THE SECRETOME OF CERVICAL CELL LINES REVEALS MATRIX REMODELING AND OXIDATIVE STRESS RESPONSE AS PIVOTAL PATHWAYS IMPLICATED IN CARCINOGENESIS See abstract > G. Georgia Kontostathi • P08-02 • ANALYTICAL PERFORMANCE OF HPV GENOTYPING METHODS ON CERVICAL LIQUID BASED CYTOLOGY SAMPLES See abstract > M. Mona Hansen • P15-01 • INVESTIGATION OF MEMBRANE PROTEINS OFFERS SIGNIFICANT INSIGHTS ON THE PROCESS OF CERVICAL CANCEROGENESIS See abstract > P. Polyxeni Christou • P12-08 • Distribution of high risk HPV genotypes in patients referred from medical offices in the Rhône-Alpes area (France) See abstract > M. Michel Labadie • P08-01 • The HPV 16 complete genome in two cervical progressive lesions from a 39-Year-Old Woman differ from each other. See abstract > F. Filomena aste Silveira • P17-05 • ANAL CANCER SCREENING: CHARACTERISTICS OF PARTICIPANTS WHO USED TWO HANDS FOR A SELF- ANAL EXAMINATION (SAE) See abstract > N. Nyitray Alan • P12-14B • THE CORRELATION BETWEEN THE MOLECULAR BIOLOGICAL DETECTION OF HUMAN PAPILLOMA VIRUS AND THE GRADE OF CERVICAL NEOPLASIA. See abstract > D. Doris Rieder • P12-15B • AN ANALYSIS OF RISK ASSESSMENT CONCERNING THE GENESIS OF CERVIX CARCINOMA. See abstract > A. Antonija Trauner • P12-14A • COMPARISON BETWEEN LIQUID BASED CYTOLOGY AND HUMAN PAPILLOMAVIRUS DETECTION AS TESTS FOR CERVICAL CANCER SCREENING. See abstract > D. Doris Rieder • P10-03 • PARP INHIBITION (OLAPARIB) IN NOVEL IN-VITRO MODELS OF OROPHARYNGEAL CANCER See abstract > E. Evelyne Pirotte • P04-07 • A population-based study on cervical cancer risk by screening history See abstract > H-C. Hui-chi Chen • P05-03 • EVALUATION OF SAMPLE CELLULARITY AND NUCLEIC ACIDS STABILITY USING COPAN ENAT MEDIUM ASSOCIATED WITH FLOQSWABS: SELF-COLLECTED VERSUS CLINICIAN-VAGINAL SAMPLING. See abstract > M. Marianna Martinelli • P17-10 • Clinical value of fully automated Ki67/p16 dual staining as biomarkers for triage of HPV positive women in a screening program See abstract > I. Irene Øvestad • P07-02 • CERVICAL MORBIDITY IN ALSACE, FRANCE. RESULTS FROM A REGIONAL ORGANIZED CERVICAL CANCER SCREENING PROGRAM See abstract > J-J. Jean-jacques Baldauf • P13-01 • COMPARATIVE STUDY OF THE IMMUNOMODULATORY PROPERTIES OF DIFFERENT CORIOLUS VERSICOLOR-BASED FORMULATIONS ADMINISTERED ORALLY OR TOPICALLY IN THE VAGINA IN HEALTHY MICE. See abstract > D. Damian Dexeus • P12-24 • HPV TESTING FOR CERVICAL CANCER SCREENING: EXPERIENCE IN CENTRO MEDICINA LABORATORIAL GERMANO DE SOUSA/HOSPITAL CUF DESCOBERTAS See abstract > M. Maria Sousa • P07-16 • TRACE ELEMENTS AND OXIDATIVE STRESS IN CERVICAL CARCINOGENESIS See abstract > R. Roberta Zappacosta • P07-17 • HPV-RELATED GENITAL DISEASE AMONG MEN RESIDING IN MEXICO See abstract > E. E Lazcano-Ponce • P12-20 • SOCIODEMOGRAPHIC, PRACTICAL AND ATTITUDINAL BARRIERS TO CERVICAL CANCER SCREENING IN UNDERSCREENED AND NEVER SCREENED JAPANESE WOMEN See abstract > S. Sharon Hanley • P12-23 • DETECTION OF HIGH GRADE CIN USING HPV DNA TESTING WITH PARTIAL GENOTYPING FOR HPV16/18 See abstract > S. Satomi Kikawa • P02-01 • COUNTERFACTUALS OF DISEASE DISCOVERY WITHIN THE FRIDA STUDY See abstract > E. Elizabeth Barrios • P11-10 • OVERCOMING BARRIERS TO ADOLESCENT VACCINATION: VACCINE CHAMPIONS’ PERSPECTIVES See abstract > J. Jennifer Smith • P17-03 • SCREENING OF CERVICAL CANCER IN SENEGAL: A STRATEGY OF INNOVATIVE HEALTH CENTER NABIL CHOUCAIR See abstract > O. Omar Gassama • P18-01 • The vaginal microbiota of women with threatened pregnancy who subsequently have ongoing pregnancy versus those who subsequently have miscarriage in the first trimester of gestation See abstract > A. Aida Akhmedova • P11-09 • PUBLIC HEALTH IMPACT AND COST EFFECTIVENESS OF A UNIVERSAL VACCINATION PROGRAMME WITH A NONAVALENT HPV VACCINE IN GERMANY See abstract > M. Mathieu Uhart